Human papillomavirus in cervical cancers of Malaysians

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 6, 2011, Pages 489-495

  Cheah, Phaik Leng ^a   Looi, Lai Meng ^a   Sivanesaratnam, Vallipuram ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Cervical carcinoma; Human papillomavirus; Polymerase chain reaction; Prevalence

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALAYSIA; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA; CERVIX UTERI; FEMALE; HUMANS; MALAYSIA; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 80052746492     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01386.x     Document Type: Article

References (39)

1. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008; 110 (3Suppl): S4-S7.
2. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference statement: Cervical cancer, 1-3 April 1996. J Natl Cancer Inst Monogr 1996; 21: vii-xix.
3. FDA. FDA News. 2006. [Cited 8 Jun 2006.] Available from URL: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.
4. EMEA. Cervarix human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed). 2008. European Medicines Agency. [Cited 20 Sep 2007.] Available from URL: http://www.emea.europa.eu/humandocs/Humans/EPAR/cervarix/ cervarix.htm.
5. Lim GCC, Rampal S, Halimah Y (eds). 3rd Report of the National Cancer Registry: Cancer Incidence in Peninsular Malaysia 2003-2005. Kuala Lumpur: National Cancer Registry, 2008.
6. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) group. J Natl Cancer Inst 1995; 87: 796-802.
7. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003; 88: 63-73.
8. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527. (Pubitemid 36159887)
9. Smith JS, Lindsay L, Hoots B et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 2007; 121: 621-632. (Pubitemid 46986496)
10. Miller BA, Davidson M, Myerson D et al. Human papillomavirus type 16 DNA in oesophageal carcinomas from Alaska natives. Int J Cancer 1997; 71: 218-222. (Pubitemid 27252994)
11. Levi JE, Rahal P, Sarkis AS, Villa L. Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 1998; 76: 779-783. (Pubitemid 28262091)
12. Cheah PL, Looi LM, Sivanesaratnam V. Recent trends in histological pattern of cervical carcinoma among three ethnic groups in Malaysia. J Obstet Gynaecol Res 1999; 25: 401-406. (Pubitemid 30028829)
13. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified beta-globin and HLADQalfa DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163-166. (Pubitemid 17180630)
14. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. HPV in full thickness cervical biopsies: High prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol 1991; 165: 301-309.
15. Ting Y, Manos M. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Snisky JJ,White TJ (eds). PCR Protocols: A Guide to Methods and Applications. New York: Academic Press, 1990; 356-367.
16. Jackson DP, Lewis FA, Taylor GR, Boylston AW, Quirke P. Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol 1990; 43: 499-504. (Pubitemid 20173188)
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold SpringHarbor Laboratory, 1989.
18. Clifford GM, Gallus S, Herrero R et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 2005; 366: 991-998. (Pubitemid 41323035)
19. Bertelsen BI, Kugarajh K, Skar R, Laerum OD. HPV subtypes in cervical cancer biopsies between 1930 and 2004: Detection using general primer pair PCR and sequencing. Virchows Arch 2006; 449: 141-147.
20. Yadav M, Nurhayati ZA, Padmanathan A, Abdul Aziz Y, Norhanom AW. Polymerase chain reaction detection and restriction enzyme typing of human papillomavirus in cervical carcinoma. Med J Malaysia 1995; 50: 64-71.
21. Padmanathan A, Yadav M, Gregory AR, Kumar S, Norhanum AW. Human papillomavirus DNA and virus-encoded antigens in cervical carcinoma. Med J Malaysia 1997; 52: 108-116.
22. Gillio-Tos A, de Marco L, Fiano V et al. Efficient DNA extraction from 25-year-old paraffin-embedded tissues: Study of 365 samples. Pathology 2007; 39: 345-348. (Pubitemid 46897597)
23. Inadome Y, Noguchi M. Selection of higher molecular weight genomic DNA for molecular diagnosis from formalin-fixed material. Diagn Mol Pathol 2003; 12: 231-236. (Pubitemid 37475231)
24. Talaulikar D, Shadbolt B, McNivens M, Dahlstrom JE. DNA amplification from formalin-fixed decalcified paraffinembedded bone marrow trephine specimens: Does the duration of storage matter? Pathology 2008; 40: 702-706.
25. Kalantari M, Garcia-Carranca A, Morales-Vazquez CD et al. Laser capture microdissection of cervical human papillomavirus infections: Copy number of the virus in cancerous and normal tissue and heterogenous DNA methylation. Virology 2009; 390: 261-267.
26. Moodley M. Update on pathophysiologic mechanisms of human papillomavirus. Curr Opin Obstet Gynecol 2005; 17: 61-64. (Pubitemid 40315266)
27. Vinokurova S, Wentzensen N, Kraus I et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008; 68: 307-313. (Pubitemid 351380133)
28. Nederhand RJ, Droog S, Kluft C, Simoons ML, de Maat MPM. Logistics and quality control for DNA sampling in large multicenter studies. J Thromb Haemost 2003; 1: 987-991.
29. Manosca F, Schinstine M, Fetsch PA et al. Diagnostic effects of prolonged storage on fresh effusion samples. Diagn Cytopathol 2007; 35: 6-11. (Pubitemid 46095107)
30. Turbett GR, Sellner LN. The use of optimal cutting temperature compound can inhibit amplification by polymerase chain reaction. Diagn Mol Pathol 1997; 6: 298-303. (Pubitemid 28047552)
31. Lim J, Kim Y, Lee W et al. Fresh-frozen, optimal cutting temperature (OCT) compound-embedded bone marrow aspirates: A reliable resource for morphological, immunohistochemical and molecular examinations. Int J Hematol 2010; 32 (1 Pt 1): e34-e39.
32. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057-1062.
33. Gravitt PE, Peyton CL, Allessi TQ et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-361. (Pubitemid 30043317)
34. Kleter B, van Doorn LJ, ter Schegget J et al. Technical advancenovel short-fragment PCR assay for highly sensitive broadspecturm detection of anogenital human papillomaviruses. Am J Pathol 1998; 153: 1731-1739. (Pubitemid 28550661)
35. Kleter B, van Doorn LJ, Schrauwen L et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517. (Pubitemid 29337270)
36. El-Mansi MT, Cuschieri KS, Morris RG, Williams ARW. Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients. Int J Gynecol Cancer 2006; 16: 1025-1031. (Pubitemid 43886721)
37. Coutlee F, Trottier H, Gagnon S et al. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. J Clin Virol 2009; 45: 96-99.
38. Harper DM. Current prophylactic HPV vaccines and gynaecologic malignancies. Curr Opin Obstet Gynecol 2009; 21: 457-464.
39. Hakim AA, Dinh TA. Worldwide impact of the human papillomavirus vaccine. Curr Treat Options Oncol 2009; 10: 44-53.